hydrazine has been researched along with Lymphoma, Large B-Cell, Diffuse in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (56.82) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (2.27) | 24.3611 |
| 2020's | 18 (40.91) | 2.80 |
| Authors | Studies |
|---|---|
| Du, J; Liu, H; Sang, N; Wei, J; Yang, S; Yang, X; Zhang, J; Zhao, Y; Zhong, X; Zhou, X; Zhou, Y; Zuo, Z | 1 |
| Bakhshi, S; Caimi, PF; Canales, M; Casasnovas, RO; Cavallo, F; Chamoun, K; Choquet, S; Egyed, M; Follows, G; Goy, A; Gurion, R; Hamad, N; Hill, B; Jaeger, U; Kalakonda, N; Kauffman, MG; Ku, M; Kuruvilla, J; la Cruz, F; Ma, X; Maerevoet, M; Neste, EVD; Offner, F; Samal, P; Sancho, JM; Schuster, M; Shacham, S; Shah, J; Thieblemont, C; Vassilakopoulos, TP; Vermaat, JSP; Warzocha, K; Zijlstra, JM | 1 |
| Chavez, JC; Logue, JM | 1 |
| Fu, JX; Ju, SG; Li, J; Ling, HY; Sun, Y; Wang, PJ; Yang, Z | 1 |
| Bakhshi, S; Caimi, P; Canales, M; Casasnovas, RO; Cavallo, F; Chamoun, K; Choquet, S; Corona, K; De la Cruz, F; Egyed, M; Follows, G; Goy, A; Gurion, R; Hamad, N; Hill, B; Jaeger, U; Kalakonda, N; Kauffman, MG; Ku, M; Kuruvilla, J; Ma, X; Maerevoet, M; Neste, EVD; Offner, F; Samal, P; Sancho, JM; Schuster, M; Shacham, S; Shah, J; Thieblemont, C; Vassilakopoulos, T; Vermaat, JSP; Warzocha, K; Zijlstra, J | 1 |
| Sylvain, C | 1 |
| Baker, S; Bhat, S; Byrd, JC; Canfield, D; Cempre, CB; Fu, Q; Hu, B; Huang, Y; Jaglowski, SM; Lapalombella, R; Lockman, H; Rogers, KA; Ruppert, AS; Shah, H; Stephens, DM; Vadeboncoeur, R; Walker, JS; Woyach, JA | 1 |
| Daelemans, D; Deconick, T; Kwanten, B; Landesman, Y; Walker, C; Wang, F | 1 |
| Ben-Barouch, S; Kuruvilla, J | 1 |
| Chiappella, A; Corradini, P | 1 |
| Bakhshi, S; Bouabdallah, R; Canales, MA; Casasnovas, O; Cavallo, F; Chang, H; Choquet, S; Corona, K; De la Cruz, F; Egyed, M; Follows, G; Goy, A; Gurion, R; Hamad, N; Hill, B; Jaeger, U; Joshi, A; Kalakonda, N; Kauffman, M; Landesman, Y; Ma, X; Maerevoet, M; McCarthy, D; Mishra, S; Offner, F; Saint-Martin, JR; Sancho, JM; Schuster, M; Shacham, S; Shah, J; Thieblemont, C; Van Den Neste, E; Vassilakopoulos, TP; Vermaat, JSP; Wang, H; Warzocha, K; Zijlstra, JM | 1 |
| Gopal, AK; Smith, SD | 1 |
| Kalakonda, N; Kauffman, M; Shah, J | 1 |
| Azmi, AS; Mohammad, RM; Uddin, MH | 1 |
| Harris, LJ; Martin, M; Patel, K | 1 |
| Bader, JC; Li, H; Shacham, S; Shah, J; Tang, S; Wada, R; Xu, H | 1 |
| Gormley, NJ; Kasamon, YL; Li, RJ; Ma, L; Okusanya, OO; Pazdur, R; Price, LSL; Richardson, NC; Theoret, M; Wu, YT | 1 |
| Bakhshi, S; Caimi, P; Canales, M; Casasnovas, RO; Cavallo, F; Chamoun, K; Choquet, S; Corona, K; De la Cruz, F; Egyed, M; Follows, G; Goy, A; Gurion, R; Hamad, N; Hill, B; Jaeger, U; Kalakonda, N; Kauffman, MG; Ku, M; Kuruvilla, J; Ma, X; Maerevoet, M; Offner, F; Samal, P; Sancho, JM; Schuster, M; Shacham, S; Shah, J; Thieblemont, C; Van Den Neste, E; Vassilakopoulos, TP; Vermaat, JSP; Warzocha, K; Zijlstra, JM | 1 |
| Abrisqueta, P; Bobillo, S; Bosch, F; Carpio, C; Castellví, J; Crespo, M; Raheja, P | 1 |
| AMIEL, JL; BERUMEN, L; BRULE, G; CATTAN, A; MATHE, G; SCHNEIDER, M; SCHWARZENBERG, L; SCHWEISGUTH, O | 1 |
| AMIEL, JL; CATTAN, A; MATHE, G; SCHLUMBERGER, JR; SCHNEIDER, M; SCHWARZENBERG, L | 2 |
| ABATUCCI, JS; JACOB, P; VIALLANEIX, JP | 1 |
| Rastetter, J; Stockhusen, G; Theml, H; Trepel, F | 1 |
| Baló, J; Juhász, J; Szende, B | 1 |
| Kühböck, J; Mannheimer, E; Pietschmann, H | 1 |
| Alexanian, R; Frei, E; Howe, CD; Leary, WV; Samuels, ML | 1 |
| Armstrong, JG | 1 |
| Shimizu, H; Toth, B | 1 |
| De Vita, VT; Myers, GH; Sherins, RJ; Van Thiel, DH | 1 |
| Garbarini, U; Valassina, GP | 1 |
| Clément, F; Jaeger, M | 1 |
| Danieli, G | 1 |
| Pergola, M; Perrone, V; Zarrilli, D | 1 |
| Finotto, E; Fiorentino, M | 1 |
| Nissen, I; Poulsen, EH | 1 |
| Almici, C; Beltrametti, L | 1 |
| Bauters, F; Goudemand, M; Lerche-Habart, B; Sautière-Habay, D | 1 |
| el-Akkad, SM; Garrett, MJ; Glazebrook, GA; Shakir, MA | 1 |
| Olweny, CL; Ziegler, JL | 1 |
| Haas, H; Meyerhold, A; Wagner, K | 1 |
| Anglesio, E | 1 |
| Hansen, MM; Hertz, H; Videaek, A | 1 |
| Snyman, HW; Spies, SK | 1 |
6 review(s) available for hydrazine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
How to Sequence Therapies in Diffuse Large B-Cell Lymphoma Post-CAR-T Cell Failure.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzodiazepines; Consolidation Chemotherapy; Humans; Hydrazines; Immune Checkpoint Inhibitors; Immunoconjugates; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Radiotherapy; Receptors, Chimeric Antigen; Stem Cell Transplantation; Treatment Failure; Triazoles | 2021 |
A drug profile on selinexor for the treatment of refractory diffuse large B-cell lymphoma.
Topics: Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Triazoles | 2022 |
Selinexor (KTP-330) - a selective inhibitor of nuclear export (SINE): anti-tumor activity in diffuse large B-cell lymphoma (DLBCL).
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Biomarkers, Tumor; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Molecular Targeted Therapy; Triazoles | 2020 |
The nuclear export protein XPO1 - from biology to targeted therapy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dexamethasone; Drug Resistance, Neoplasm; Exportin 1 Protein; Hematologic Neoplasms; Humans; Hydrazines; Karyopherins; Lymphoma, Large B-Cell, Diffuse; Molecular Targeted Therapy; Receptors, Cytoplasmic and Nuclear; Triazoles | 2021 |
Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Topics: Adoptive Transfer; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Humans; Hydrazines; Immunoconjugates; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Triazoles | 2020 |
FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Topics: Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Multicenter Studies as Topic; Neutropenia; Treatment Outcome; Triazoles | 2021 |
7 trial(s) available for hydrazine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.
Topics: Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Triazoles | 2022 |
Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study.
Topics: Adenine; Adult; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Piperidines; Pyrazoles; Pyrimidines; Triazoles | 2022 |
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Exportin 1 Protein; Female; Humans; Hydrazines; Karyopherins; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Receptors, Cytoplasmic and Nuclear; Triazoles | 2020 |
Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.
Topics: Age Factors; Aged; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome; Triazoles | 2021 |
Clinical trials with N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia.
Topics: Adenocarcinoma; Adult; Aged; Amines; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Clinical Trials as Topic; Hodgkin Disease; Humans; Hydrazines; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multiple Myeloma; Mycosis Fungoides; Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Wilms Tumor | 1967 |
Treatment of histiocytic lymphoma in Uganda adults.
Topics: Adult; Cyclophosphamide; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Hydrazines; Injections, Intravenous; Lymphoma, Large B-Cell, Diffuse; Male; Mechlorethamine; Neoplasm Recurrence, Local; Prednisone; Remission, Spontaneous; Uganda; Vincristine | 1971 |
[Treatment of Hodgkin's disease with Natulan].
Topics: Antineoplastic Agents; Clinical Trials as Topic; Female; Hodgkin Disease; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Male; Plasmacytoma | 1965 |
31 other study(ies) available for hydrazine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Histone Demethylases; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Mice, Inbred NOD; Mice, SCID; Morpholines; Sulfones; Xenograft Model Antitumor Assays | 2021 |
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Treatment Outcome; Triazoles | 2022 |
Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.
Topics: Cell Line, Tumor; Cytokine Receptor gp130; Exosomes; Humans; Hydrazines; Immunophenotyping; Lymphoma, Large B-Cell, Diffuse; Models, Biological; Phenotype; Quinoxalines; Signal Transduction; STAT3 Transcription Factor; Tumor Microenvironment; Tumor-Associated Macrophages | 2022 |
E3 ubiquitin ligase ASB8 promotes selinexor-induced proteasomal degradation of XPO1.
Topics: Active Transport, Cell Nucleus; Humans; Hydrazines; Karyopherins; Lymphoma, Large B-Cell, Diffuse; Multiple Myeloma; Suppressor of Cytokine Signaling Proteins | 2023 |
Selective inhibitors of nuclear export in aggressive B-cell lymphomas.
Topics: Active Transport, Cell Nucleus; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Triazoles | 2020 |
Selinexor for relapsed or refractory diffuse large B-cell lymphoma: examining the artifact.
Topics: Artifacts; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Triazoles | 2020 |
Selinexor for relapsed or refractory diffuse large B-cell lymphoma: examining the artifact - Authors' reply.
Topics: Artifacts; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Triazoles | 2020 |
Selinexor population pharmacokinetic and exposure-response analyses to support dose optimization in patients with diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clinical Studies as Topic; Female; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Treatment Outcome; Triazoles; Young Adult | 2021 |
Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement.
Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Compassionate Use Trials; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Salvage Therapy; Triazoles | 2018 |
METHYL-HYDRAZINE IN TREATMENT OF HODGKIN'S DISEASE AND VARIOUS FORMS OF HAEMATOSARCOMA AND LEUKAEMIA.
Topics: Antineoplastic Agents; Hodgkin Disease; Hydrazines; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms; Sarcoma; Vinblastine | 1963 |
[ATTEMPT AT TREATMENT OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS WITH 1-METHYL-2-P-ALLOPHANOYL-BENZYLHYDRAZINE HYDROBROMIDE].
Topics: Antineoplastic Agents; Hodgkin Disease; Humans; Hydrazines; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Mycosis Fungoides; Neoplasms; Sarcoma | 1964 |
[CLINICAL TRIALS OF A METHYLHYDRAZINE DERIVATIVE AND ITS COMBINATION WITH TELECOBALT THERAPY].
Topics: Antineoplastic Agents; Cobalt Isotopes; Drug Therapy; Esophageal Neoplasms; Female; Hodgkin Disease; Humans; Hydrazines; Laryngeal Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methylhydrazines; Neoplasms; Pharyngeal Neoplasms; Radioisotope Teletherapy; Sarcoma; Uterine Cervical Neoplasms | 1964 |
[Nucleic acid synthesis and cytostatic drug effect in pathological lymph node cells].
Topics: Aged; Antineoplastic Agents; Dactinomycin; Depression, Chemical; DNA, Neoplasm; Hodgkin Disease; Humans; Hydrazines; Hyperplasia; Leukemia; Lymph Nodes; Lymphadenitis; Lymphatic Diseases; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms; Nitrogen Mustard Compounds; Nucleosides; Prednisolone; RNA, Neoplasm; Thymidine; Tritium; Vinblastine | 1966 |
[The tumor-inducing action of hydrazine].
Topics: Animals; Carcinogens; Child, Preschool; Female; Humans; Hydrazines; Isoniazid; Leukemia; Liver; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinum; Mice; Neoplasms, Experimental; Spleen | 1967 |
[Cytostatic therapy of hemoblastoses and malignant tumors with a methylhydrazine derivative].
Topics: Adolescent; Adult; Aged; Bone Marrow Examination; Breast Neoplasms; Carcinoma, Bronchogenic; Female; Hodgkin Disease; Humans; Hydrazines; Kidney Neoplasms; Leukemia; Lymphadenitis; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Middle Aged; Sarcoma, Synovial | 1966 |
Current problems in the use of the oncolytic drugs.
Topics: Antineoplastic Agents; Busulfan; Carcinoma, Squamous Cell; Child; Chlorambucil; Choriocarcinoma; Dactinomycin; Female; Fluorouracil; Gonadal Steroid Hormones; Hodgkin Disease; Humans; Hydrazines; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Mesenchymoma; Methotrexate; Multiple Myeloma; Nitrogen Mustard Compounds; Ovarian Neoplasms; Pregnancy; Prostatic Neoplasms; Steroids; Testicular Neoplasms; Urethane; Vinblastine; Vincristine; Wilms Tumor | 1968 |
Methylhydrazine tumorigenesis in Syrian golden hamsters and the morphology of malignant histiocytomas.
Topics: Animals; Carcinogens; Cecal Neoplasms; Cell Nucleus; Cricetinae; Cytoplasm; Female; Hydrazines; Inclusion Bodies; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Microscopy, Electron; Neoplasms, Experimental | 1973 |
Evidence for a specific seminiferous tubular factor affecting follicle-stimulating hormone secretion in man.
Topics: Adult; Biopsy; Cell Count; Clomiphene; Cyclophosphamide; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Hydrazines; Infertility, Male; Luteinizing Hormone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Prednisone; Radioimmunoassay; Semen; Spermatogenesis; Spermatozoa; Testis; Testosterone; Vincristine | 1972 |
[Report of a case of Lyell's syndrome during a course of treatment with Natulan].
Topics: Antineoplastic Agents; Autopsy; Female; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Stevens-Johnson Syndrome | 1973 |
[Long-term treatment of Waldenström's disease with methylhydrazine].
Topics: Blood Protein Electrophoresis; Humans; Hydrazines; Immunoelectrophoresis; Immunoglobulins; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Waldenstrom Macroglobulinemia | 1972 |
[Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Arsenicals; Colchicine; Hodgkin Disease; Humans; Hydrazines; Immunosuppressive Agents; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma | 1966 |
[Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Child, Preschool; Female; Hodgkin Disease; Humans; Hydrazines; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Nasopharyngeal Neoplasms; Tonsillar Neoplasms | 1966 |
[Action of procarbazine in malignant lymphomas].
Topics: Amides; Hodgkin Disease; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse | 1968 |
[Personal experience on the chemotherapy of leukemias and hematosarcomas].
Topics: Antineoplastic Agents; Drug Synergism; Hodgkin Disease; Humans; Hydrazines; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Mycosis Fungoides; Vinblastine; Vincristine | 1968 |
[Chemotherapy of malignant systemic diseases with a methylhydrazine derivative, Natulan].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Female; Hodgkin Disease; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged | 1967 |
[Methylhydrazine in the therapy of malignant lymphopathies].
Topics: Hodgkin Disease; Humans; Hydrazines; Leukemia, Lymphoid; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin | 1967 |
[Association of nitrogen mustard, vincristine, methylhydrazine and prednisone in treatment of diffuse forms of Hodgkin's disease and ganglionic sarcomas].
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Synergism; Female; Hodgkin Disease; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Time Factors; Vincristine | 1968 |
Combination chemotherapy in malignant disease.
Topics: Administration, Oral; Blood Cell Count; Breast Neoplasms; Bronchial Neoplasms; Child, Preschool; Female; Hodgkin Disease; Humans; Hydrazines; Injections, Intravenous; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Multiple Myeloma; Neoplasms; Prednisolone; Radiography; Remission, Spontaneous; Sarcoma, Ewing; Vinblastine | 1971 |
[Experiences with Natulan in the treatment of lymphogranulomatosis and reticulosarcomatosis].
Topics: Antineoplastic Agents; Hodgkin Disease; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Radiography, Thoracic | 1965 |
Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Agents; Child; Female; Hodgkin Disease; Humans; Hydrazines; Leukemia, Lymphoid; Leukopenia; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Thrombocytopenia | 1966 |
Procarbazine (Natulan) in the treatment of Hodgkin's disease and other lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Female; Hodgkin Disease; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mycosis Fungoides | 1966 |